FDA grants approval for Eylea®1) biosimilar FYB203/AHZANTIVE®2) (aflibercept-mrbb)

Retrieved on: 2024-06-29 10:00:22

Tags for this article:

Click the tags to see associated articles and topics

FDA grants approval for Eylea®1) biosimilar FYB203/AHZANTIVE®2) (aflibercept-mrbb). View article details on hiswai:

Excerpt

June 2024 – Formycon AG (FSE: FYB, “Formycon”) and its licensing partner Klinge Biopharma GmbH ("Klinge") announce that the U.S. Food and Drug ...

Article found on: www.pharmiweb.com